NCT00249899 - Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia | Biotech Hunter

Enrollment

649

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Hypercholesterolemia

Interventions

DRUG

Lapaquistat acetate and stable statin therapy

Lapaquistat acetate 100 mg, tablets, orally, once daily and stable statin therapy for up to 24 weeks.

DRUG

Stable statin therapy

Lapaquistat acetate placebo-matching, tablets, orally, once daily and stable statin therapy for up to 24 weeks.

Trial Locations (23)

Santa Ana

Chicago

Iowa City

Kansas City

Auburn

Scarborough

Baltimore

St Louis

Concord

Cincinnati

Houston

Salt Lake City

Seattle

Calgary

Vancouver

Chicoutimi

Laval

Montreal

Ste-Foy

Bellville

Johannesburg

Parow

Pretoria